- CA$36.21m
- CA$36.11m
- 27
- 51
- 38
- 32
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.37 | 0.285 | 0.535 | 10.6 | 8.22 |
Operating Profit | -5.37 | -0.285 | -0.535 | -10.6 | -8.22 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.47 | -0.321 | -0.535 | -10.6 | -8.29 |
Net Income After Taxes | -5.47 | -0.321 | -0.535 | -10.6 | -8.29 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.47 | -0.321 | -0.535 | -10.6 | -8.29 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.47 | -0.321 | -0.535 | -10.6 | -8.29 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.241 | -0.074 | -0.044 | -0.26 | -0.138 |